Single shot antibiotic approved for skin infections


Intravenous antibiotic Orbactiv (oritavancin), from US firm The Medicines Company, has been approved by the US Food and Drug Administration (FDA). The drug can be used to treat acute bacterial skin and skin structure infections (ABSSSIs) caused by susceptible gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA).

Orbactiv is the third drug to be approved (all for ABSSSIs) under the FDA’s incentive programme for encouraging companies to develop new antibiotics. It joins Durata Therapeutics' Dalvance (dalbavancin), which was approved in May, and Cubist’s Sivextro (tedizolid), approved in June. All three were designated as Qualified Infectious Disease Products, since they combat pathogens on the FDA’s list of serious or life-threatening infections. That designation entitles the companies to speedier reviews of their regulatory applications, as well as an extra five years’ market exclusivity to take into account the restricted use of new antibiotics limiting sales.

Orbactiv and Dalvance are intravenous drugs with structures related to the current drug of last resort, vancomycin. Both are administered intravenously – Orbactiv in a single dose, compared to three infusions of Dalvance or 7–10 days of twice-daily vancomycin infusions. Sivextro is approved for both oral and intravenous use.


Related Content

Pepping up antibiotics

29 September 2014 Premium contentFeature

news image

Industry and academia are turning to antimicrobial peptides to find new antibiotics, Andy Extance discovers

Re-arming the antibiotic arsenal

26 September 2013 Feature

news image

How can we make new antibiotics? Phillip Broadwith takes a look

Most Read

Hydrogel with a basic instinct for drug delivery

15 April 2015 Research

news image

Gel that releases naproxen in alkaline surroundings is promising step toward relieving drug’s side effects

Early Earth collision could clear up two geological mysteries

16 April 2015 Research

news image

Smash-up with Mercury-like body could have ignited nuclear dynamo at Earth's centre and explain isotope discrepancy

Most Commented

Membrane-less electrolyser set to disrupt water splitting

20 April 2015 Research

news image

Device that exploits fluid mechanic forces has potential to significantly cut cost of hydrogen production

Oh, the humanities!

20 April 2015 The Crucible

news image

Science and the arts are equally essential to society, says Philip Ball. Don’t divide them by their differences